1. Hudson, J.Q., 2002. Chronic Kidney Disease: Management of Complications. In J. T.

Dipiro., Talbert, R.L., Yee, G. C., Matzke, G. R., Wells, B. G. & Posey, L. M, eds.
Pharmacotherapy A Pathophysiological Approach. The McGrawHill Companies
2. The Renal Association. 2013. CKD Stages. Diakses dari:
http://www.renal.org/information-resources/the-uk-eckd-guide/ckdstages#
sthash.frm4MEB8.dpbs.
3. Wilson, L.M. 2005. Gagal Ginjal Kronik. Dalam: Wilson, L.M., Price, S.A.,
penyunting. Patofisiologi: konsep klinis proses-proses penyakit. Edisi ke-6.
Jakarta:ECG. hlm. 912–47.
4. Suwitra K. Penyakit Ginjal Kronik. In: Sudoyo AW, Setiyohadi B, Alwi I, et al., 3rd
ed. Buku Ajar Ilmu Penyakit Dalam. Jakarta: InternaPublishing 2009:1035-1040.
5. Crews DC, Plantinga LC, Miller ER, 3rd, et al. Prevalence of chronic kidney disease in
persons with undiagnosed or prehypertension in the United States. Hypertension
[Internet]. 2010 [cited 2013 sept 4]; 55(5):1102-1109. Available from:
HypertensionAHA.
6. Scottish Intercollegiate Guidelines Network. 2008. Diagnosis and management of
chronic kidney disease: a national clinical guideline.
7. Yasir, R., Maiyesi, A. 2012. Pemeriksaan laboratorium cystatin c untuk uji fungsi
ginjal. Jurnal Kesehatan Andalas. 1(1):10–5.
8. National Kidney Foundation. 2010. Keeping Your Heart Healthy What You Should
Know About Lipids.
9. Rahardjo, P., Susalit, E., Suhardjono. 2009. Hemodialisis. Dalam: Sudoyo , A.W.,
Setiyohadi, B., Alwi, I., Simadribata, M.K., Setiati, S., penyunting. Buku Ajar Ilmu
Penyakit Dalam. Edisi ke-5. Jakarta: Interna Publishing. hlm. 1050–2.
10. Jha V. Periotoneal dialysis in India: current status and challenges. PeritDial Int
2008;28:36-41.
11. Yu AWY, Chau KF, Ho YW, Li PKT. Development of the “Peritoneal Dialysis First”
model in HongKong. Perit Dial Int 2007;27:53-5.
12. Dixon BF and Vecihi B. Assessment and Mangement of Renal Transplantation Patient.
Medscape, update Jul 21,2015.
13. Pau TRT, Michelle W, Nadey H, David T, and Vassilios P. Renal Transplantation. BMJ
2011;343, pp 1-8
14. Bucurescu G. 2008. Uremic Encephalopathy. 20 November 2012
www.emedicine.medscape.com/nephrology
15. Pan, Y. 2013. Uremic Neuropathy. Available from: http://emedicine.medscape.com/
16. Koda – Kimbel, M.A., Yee, Y.L., Brian, A.K., Robin, C.L., Joseph, G.B., Wayne, K.A.,
Bradley, W.R., 2009, Applied Therapeutics; The Clinical Use of Drugs, 9th
Ed,Appeton and Lange:Philadelphia.
17. Alper AB. Uremia [internet]. USA: Medscape; 2016. Tersedia dari
http://emedicine.medscape.com/article/245296-overview.
18. Shirazian, S. 2011. Gastrointestinal Disorders and Renal Failure. Available from:
http://emedicine.medscape.com/
19. Parmar, M.S. 2015. Hemolytic Uremic Syndrome. Available from :
http://emedicine.medscape.com/
20. Brunner. L., Suddarth, D,2002, Buku Ajar Keperawatan Medikal Bedah,1,EGC:Jakarta
21. Rowe CP, Orrbine E, Wells GA, Mc Laine PN. of hemolytic uremic syndrome. Pediatr
Nephrol, (1991). Epidemology of hemolytic-uremic syndrome in Canadian children
from 1986 to 1988. J Pediatr, 119:218-24
22. Mahadewa. TGB (ed). 2013. Saraf Perefer Masalah dan Penangananya. Jakarta: Indeks.
23. Kitchen, S. 2002; Electrotherapy Evidence – Based Practice. Ed.11th. Churchiil
Livingstone: Edinburg.
24. Arovah, Novita Intan. 2010. Dasar-dasar Fisioterapi pada Olahraga. Yogyakarta:
Universitas Negeri Yogyakarta.
25. Parjoto, Slamet. 2006. Terapi Listrik Untuk Modulasi Nyeri. Semarang: Ikatan
Fisioterapi Indonesia Cabang Semarang.
26. Lieberman, Michael, Marks Allan D, 2009. Basic Medical Biochemistry: A Clinical
Approach (Third Edition). Walter Clawer, Lippincott Williams dan Wilkins:
Philadelphia, Baltimore, New York, London, Buenos Aires, Hongkong, Sydney,
Tokyo.
27. Shelerud RA, Paynter KS. Rarer causes of radiculopathy: spinal tumors, infections, and
other unusual causes. Phys Med Rehabil Clin N Am. 2002 Aug. 13(3):645-96.
28. Kostova E., Javanoska E., Zafirov D, Jakovski K, Maleva, and Slaninka-Miceska M.
2005. Dual inhibition of angiotensin converting enzyme and neutral endopeptidase
produces effective blood pressure control in spontaneously hypertensive rats. Bratisl
Lek listy, 106(12): 407-411.
29. Horst ES, Johnson C, Lebowitz HE: Carbohydrate metabolism in uremia. Ann Intern
Med 68: 63–76, 1968 [PubMed]
30. Snyder RW, Bernds JS: Use of insulin and oral hypoglycemic medications in patients
with diabetes mellitus and advanced kidney disease. Semin Dial 17: 365–370, 2004
[PubMed]
31. Sherwood L. Fisiologi manusia dari sel ke sistem. Edisi ke-6. Jakarta: EGC; 2012.
32. Guyton AC, Hall JE. Buku ajar fisiologi kedokteran. Edisi ke-11. Jakarta: EGC; 2010.
33. 7. Deguchi T, Isozaki K, Yousuke k, Terasaki T, Otagiri M. Involvement of organic
anion transporters in the efflux of uremic toxins across the blood-brain barrier. J Neuro-
Chem. 2006; 96:1051-9.
34. Deyn PP, D’hooge R, Bogaert PP, Marescau B. Endogenous guanidino compounds as
uremic neurotoxins. Kidney Int J. 2010; 59:77-83.
35. Sukandar E. Nefrologi klinik. Edisi ke-3. Bandung: Pusat Informasi Ilmiah bagian Ilmu
Penyakit Dalam Fakultas Kedokteran UNPAD/RS. Dr. Hasan Sadikin; 2006.